Biotech Investment Analyst — Drug Asset & Company Assessment
Listing checked August 29, 2026 · pay as published by Mercor
Overview
Mercor is teaming up with a biotech and pharma research group to support expert human evaluation, where you'll build and refine rubrics for assessing commercial medications and drug pipelines. This is a paid, part-time pilot gig that could turn into ongoing work as the project grows. If you have deep experience analyzing biotech assets from a specialist-fund perspective, this is a chance to put that expertise to work remotely.
What You'll Do4
- 1Design and critique scoring rubrics used to evaluate marketed drugs and development-stage programs
- 2Deliver full assessments of companies and their drug assets, covering mechanism of action, clinical evidence, competitive landscape, and key value drivers
- 3Review investment-style theses for quality, identifying unsupported, overly bullish, or missing assumptions
- 4Apply your evaluation approach consistently across a pilot set of roughly 5–10 companies
Requirements4
- 1US-based biotech or healthcare investment analyst with a specialist-fund background
- 2At least 5 years of experience evaluating biotech and pharma companies or their assets
- 3Familiarity with biotech and pharma development programs, from early-stage research through commercialization
- 4Ability to assess both the drug asset and the underlying company end-to-end in a structured way
Who Should Apply
You're an experienced biotech analyst who has spent years on the specialist-fund side, deep in drug development and company valuations. You're comfortable judging both the science and the numbers, and you can quickly spot where an investment thesis is thin or overconfident. You enjoy structured, critical evaluation and want to help improve how AI assesses drug programs.
Salary Insight
The role pays $120–$200 per hour, and the pilot is roughly 10–20 hours over 1–2 weeks.
Pay and demand for Business Analysis & Strategy roles
AggregatedTypical pay
$92/hour
This role
$120–$200/hr
Most Business Analysis & Strategy roles pay $75–$125 per hour. This role's pay sits above that range.
Based on 36 similar roles that publish pay · 1 publishes only a top rate; those count at the rate they gave
Rates shown per hour. Yearly and monthly pay converted; one-time fees and non-USD pay are not included.
- Live similar roles
- 74
- Listed in last 30 days
- 22
- Remote
- 95%
Hiring most right now: Turing (30) · Mercor (11) · AfterQuery (10)
Most requested skills · share of roles
- excel42%
- business analysis41%
- data interpretation36%
- logical reasoning36%
Figures from Business Analysis & Strategy roles live on NearSkill when this page loaded. A role can close before you apply, so check the listing itself.
Compare your resume against these rolesLocation
Compensation
$120–200/hr
Required Skills
Application Tip
In your application, walk through one specific drug asset you've assessed end-to-end — focus on how you weighed clinical data against commercial potential and where you found the biggest gap in the company's own thesis.
How NearSkill helps you apply
1. Check your job match
We compare your resume with the job requirements to help you understand how well your experience fits.
2. Continue to the employer’s website
We’ll direct you to the employer’s application portal, where you can complete the application.
3. Get updates by email
If NearSkill is handling follow-up for this role, we’ll email you when there’s an update on your screening.
Want to check your fit first?
See how your resume matches this role before applying.
Check my job matchSimilar open positions
Explore active roles that match your skills and interests.
Mercor
VerifiedPreclinical R&D Expert – In-house Drug Development
An AI lab backed by venture capital is building physics-based foundation models for chemistry, materials science, and drug discovery. The lab works with Mercor to bring in hands-on preclinical R&D experts who guide how AI systems interpret real pharmaceutical data. This remote contract runs about 10 hours per week and pairs bench-level scientific judgment with data annotation work. Your feedback on drug development decisions and data quality shapes how models reason about new medicines.
Mercor
VerifiedPreclinical R&D Expert – ADC & Bispecifics
Mercor is hiring a preclinical R&D expert to support a venture-backed AI lab that builds physics-based foundation models for chemistry, materials science, and drug discovery. You would contribute hands-on experience with antibody-drug conjugates (ADCs) and/or bispecific antibodies to a remote, part-time consulting role. The work centers on reviewing real R&D data, annotating scientific outputs, and advising on target and modality decisions. Your input will directly shape how AI models reason about pharmaceutical development.
Mercor
VerifiedDisease-Area Clinician — Trial Endpoints & Prescribing
This is a paid, part-time consulting opportunity for a practicing US-based clinician to lend their expertise to an AI evaluation initiative in the pharma and biotech space. You'll help design and assess scoring frameworks that examine commercial drugs and development pipelines, with a focus on clinical trial outcomes and their practical impact on prescribing. The initial engagement is a short pilot, with the possibility of ongoing work for strong performers.
Mercor
VerifiedPharma Commercial Forecasting Expert — Launch Curves
We're partnering with a biotech and pharma research team to improve expert AI evaluation of commercial drugs and drug-development programs. We need a US-based pharma commercial forecasting pro to lend their expertise in a paid pilot, building and stress-testing the rubrics used to judge commercial potential. The engagement is short and remote, with a clear path to recurring work for strong contributors.
Mercor
VerifiedPayer & Market Access Expert — Gross-to-Net & Formulary Strategy
We're looking for a seasoned payer and market access professional to join a short paid pilot with a biotech/pharma research team. You'll help build and refine evaluation frameworks that test how well commercial drug assumptions hold up against real payer behavior. Strong performance could lead to ongoing work as the project expands.
Mercor
VerifiedBiotechnology Expert - AI Training
Biotechnology experts join Mercor's network to create and judge training material for frontier AI models. Projects ask you to write development problems from programs you ran, covering the modality, process step, and specification a model must meet, then supply the reference answer that sets the grading bar. You also score model-written work on process development and assay development, checking scale-up assumptions, potency assay claims, and release criteria. Some tasks involve calling out proposals that look defensible yet would fail a developability assessment because of manufacturability, stability, or regulatory limits. The listing stays open as a standing pool, so work arrives when a client project matches your background.